Research
Neural
GLP-1 receptor agonists (GLP-1RAs) may have neuroprotective and neurotrophic effects in ALS models.
GLP-1RAs may be considered for further investigation in ALS treatment.
StrongSupportsmedium confidence
Preclinical studies suggest that GLP-1 signaling can provide neuroprotective and neurotrophic effects in ALS models.
Why this rating
Based on preclinical studies mentioned in the abstract.
Source
Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists
Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →